-+ 0.00%
-+ 0.00%
-+ 0.00%
DR. REDDY’S ANNOUNCES THE FIRST-TO-MARKET LAUNCH OF SUGAMMADEX INJECTION 200 MG/2 ML (100 MG/ML) AND 500 MG/5 ML (100 MG/ML) SINGLE-DOSE VIALS, A GENERIC EQUIVALENT OF BRIDION®, IN THE UNITED STATES
Share

Please log in to view news

Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.
What's Trending